Previous close | 2.0000 |
Open | 2.5000 |
Bid | 1.3500 |
Ask | 4.7000 |
Strike | 75.00 |
Expiry date | 2024-05-17 |
Day's range | 1.9300 - 2.5000 |
Contract range | N/A |
Volume | |
Open interest | 66 |
Comprehensive Analysis of Ligand's First Quarter Financial Performance and Future Outlook
Ligand (LGND) delivered earnings and revenue surprises of 6.19% and 4.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
JUPITER, Fla., May 07, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three months ended March 31, 2024, and provided an operating forecast and business updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern Time to discuss this announcement and answer questions.